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Josè M. Garcia Ruiz, MD,* Francesco Faita, MSC,† Elisabetta Bianchini, MSC,†
M. Urooj Zafar, MBBS,* Valentin Fuster, MD, PHD,* Mario J. Garcia, MD,‡
Juan J. Badimon, PHD*
New York and Bronx, New York; and Pisa, Italy
O B J E C T I V E S The aims of this study were to investigate the feasibility of contrast-enhanced
ultrasound (CEU) imaging for in vivo visualization of intraplaque neovascularization and to correlate the
in vivo observations with histological assessment of neovessel density and plaque composition in an
experimental animal model of advanced atherosclerosis.
B A C KG ROUND Recent evidence has linked plaque angiogenesis with enhanced atherosclerotic
plaque progression and vulnerability. Increased neovascularization has been detected in ruptured
human lesions and is associated with clinical manifestations of plaque rupture.
METHOD S Advanced aortic atherosclerosis was induced in New Zealand white rabbits (n 21; high
cholesterol–rich diet/double-balloon aortic denudation). Animals underwent standard and CEU imaging
at the end of the atherosclerosis induction period. Six age-matched animals served as control subjects.
Within 24 h, animals were euthanized and aortas processed for histopathological evaluation of plaque
composition and neovascularization. Imaged plaques were classiﬁed as contrast enhanced (CE) positive
or CE negative, according to their contrast enhancement on CEU imaging. The lesions were also
classiﬁed as class III (predominantly echogenic) or class II (predominantly echolucent), according to their
echogenicity on non-CEU images.
R E S U L T S No contrast enhancement was observed in control animals. In atherosclerotic animals,
class III lesions showed an increased contrast enhancement compared with class II lesions and
CE-positive lesions showed greater neovascularization than CE-negative plaques. Macrophage density,
but not smooth muscle cell density, was signiﬁcantly higher in CE-positive than CE-negative lesions. As
expected, class III lesions showed increased macrophage density compared with class II plaques.
Intraplaque neovessel density at histology was signiﬁcantly higher in CE-positive than in CE-negative
lesions. Class III plaques showed a signiﬁcantly higher neovessel density compared with class II lesions.
A strong correlation between intraplaque neovessels and contrast enhancement was found.
CONC L U S I O N S CEU imaging is a feasible noninvasive imaging modality to evaluate intraplaque
neovascularization. A noninvasive imaging modality to assess lesion neovascularization could be of great
importance to identify vascularized, “high-risk” lesions before rupture. (J Am Coll Cardiol Img 2010;3:
1256–64) © 2010 by the American College of Cardiology Foundation
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1257ardiovascular events, resulting from plaque
rupture and occlusive atherothrombosis, are
still the number one cause of death in the
Western countries, with approximately 1.2
illion heart attacks and 750,000 strokes afflicting the
merican population each year (1). Accumulating
vidence has linked plaque angiogenesis with en-
anced lesion progression and vulnerability (2,3). In-
reased neovascularization has been detected in rup-
ured human aortic plaques and is frequently
ssociated with pathological signs of plaque vulnera-
ility such as intraplaque hemorrhage and thin-cap
broatheromas (4–9). Therefore, the availability of a
oninvasive technique capable of reliably identifying
esion neovascularization could be particularly attrac-
ive for early detection of high-risk, prone-to-rupture
laques before the occurrence of clinical events.
Contrast-enhanced ultrasound (CEU) imaging has
een proposed as a feasible and effective technique to
etect neovascularization of human atherosclerotic
laque (10–12). The direct visualization of contrast
icrobubbles within plaque neovascularization was
reviously described (13,14). These findings were
onfirmed by a more recent study correlating CEU
maging of carotid arteries with the presence and
egree of intraplaque neovascularization as corrobo-
ated by histology of the same lesions (15). Visualiza-
ion of adventitial vasa vasorum in carotid arteries in
atients with or without carotid atherosclerosis was
ecently reported using CEU imaging (16). Despite
he promising potential application of CEU imaging
n the clinical setting, few studies have included
istological validation of the imaging results. The ones
hat did were limited to high-risk lesions collected
rom patients undergoing surgical procedures. More-
ver, the fact that carotid endarterectomy specimens
o not include the whole arterial wall limits the
istological evaluation to intraplaque neovasculariza-
ion and may exclude the assessment of adventitial
asa vasorum.
The aims of this study were to investigate the
easibility of CEU imaging for in vivo visualization
f intraplaque and adventitial neovascularization in
n experimental animal model of advanced athero-
clerosis and to correlate the in vivo observations
ith a systematic histological assessment of neoves-
el density and plaque composition.
E T H O D S
xperimental design. Aortic atherosclerosis was in-
uced in New Zealand white male rabbits (n  21)
y a combination of 0.2% cholesterol-rich diet and iortic balloon endothelial injury. Six age-matched
nimals maintained on normal chow served as
ontrol subjects. At the end of the atherosclerosis
nduction, all animals underwent standard and
EU imaging of the aorta, using a crossover design.
he animals were randomized to initial ultrasound
maging with either sonographic contrast or saline,
nd after an interval of 48 h, the studies were
epeated using the other agent (saline/contrast). On
ompletion of the imaging studies, the rabbits were
uthanized and their aortas processed for histopa-
hology. The study protocol was approved by the
nstitutional Animal Care and Use Committee.
therosclerosis induction. Atherosclerosis was in-
uced using a previously described protocol (17,18).
riefly, male New Zealand white rabbits (3.9  0.5
g) were fed a 0.2% cholesterol atherogenic diet
Research Diets Inc., New Brunswick, New Jersey) for
months. At 12 and 24 weeks of atherogenic diet
nitiation, aortic balloon endothelial denuditions were
erformed with a 3- to 4-F Fogarty catheter (Edwards
ifesciences, Irvine, California) under fluoroscopic
uidance. The femoral artery was carefully dissected to
void any nerve damage, and the catheter
as progressed until the thoracic descending
orta. The balloon was gently inflated and
ulled back until the iliac bifurcation. This
rocedure was repeated 3 times. Subse-
uently, the catheter was removed and the
emoral artery closed. Anesthesia for the
ortic denuditions and imaging process was
nduced by intramuscular injection of ketamine (30
g/kg) and xylazine (2.2 mg/kg). Imaging studies
ere performed as described in the following ultra-
ound imaging section. After completion of the im-
ging studies, animals were euthanized by pentobar-
ital overdose (75 mg/kg, Sleepaway, Fort Dodge,
ort Dodge, Iowa), and the aortas were harvested and
rocessed for histopathology. All animals received
umane care in compliance with the Guidelines for
he Care and Use of Laboratory Animals.
ltrasound imaging. Ultrasound imaging was per-
ormed (Philips iEE33 ultrasound machine, Phil-
ps, Bothell, Washington), using a 15-MHz linear
robe. Image sequences were not electrocardiogra-
hy gated and the second harmonic detection tech-
ique was used for signal detection. First, the
nfrarenal abdominal aorta was imaged and the
laques localized at the far (posterior) wall of
he vessel were selected. This anatomic landmark
llowed for a more accurate identification of the
elected plaques in the second ultrasound exam-
A B B
A N D
CE
CEU
ultrasnation as well as for histopathology, usingR E V I A T I O N S
A C R O N YM S
contrast enhanced
contrast-enhancedrenal
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1258rteries as anatomic landmarks. This criterion
as not a limitation in identifying atherosclerotic
laques because all the atherosclerotic rabbits
howed plaques at the infrarenal tract. Each
laque was classified according to its echogenicity
uring ultrasound imaging, using a conventional
lassification scheme reported previously (15):
lass I  uniformly echolucent; class II  pre-
ominantly echolucent; class III  predomi-
antly echogenic; class IV  uniformly echo-
enic; and class V  extensive calcification with
coustic shadows.
After standard ultrasound imaging, animals un-
erwent CEU imaging of previously identified le-
ions using saline or contrast agent. The sono-
raphic contrast agent perflutren lipid microspheres
Definity, Bristol-Myers Squibb Medical Imaging,
orth Billerica, Massachusetts) was intravenously
njected (0.2 ml containing 2.4  109 perflutren
ipid microspheres) via the marginal ear vein and
ushed with 1 ml of saline. Image settings were
djusted to maximize contrast signal visualization
nd a low mechanical index was used (0.06 to
.08). A preliminary study was performed to
stablish the most favorable dose and administra-
ion as well as optimization of image settings.
he studies were digitally stored for subsequent
nalysis. Standard and contrast-enhanced images
ere reviewed offline by 2 readers (E.B., F.F.).
During CEU examinations, plaques appeared
ark and hypoechoic because of tissue signal
uppression. The movement of the echogenic
ubbles into the previously identified atheroscle-
otic lesions generated moving bright spots
ithin the adventitia and the core of the plaque.
ccording to plaque contrast-agent enhance-
ent, each lesion was categorized either as CE
egative (no signal within the plaque or confined
o plaque adventitial side) or CE positive (signal
eaching the plaque core and/or extensive con-
rast agent enhancement throughout the lesion),
s previously described (15).
Contrast signal enhancement was quantified by a
ustomized semiautomatic analysis program
MATLAB, The MathWorks, Inc., Natick, Mas-
achusetts). The regions of interest, including
laque and adventitia, were set in the ultrasound
-mode images, in a sequence of 10 images before
nd after contrast/saline injection. Mean gray scale
f the images pre- (baseline) and post-injection was
alculated and contrast-enhancement expressed as
he percentage of increase of mean gray scale versus
aseline (pre-infusion) image. Interobserver vari- nbility data for the lesion classification was 5% and
or the quantitative data was 6%.
istopathology and immunohistochemistry. After the
nal imaging session, the animals were euthanized
nd the abdominal aorta perfused with phosphate-
uffered saline 1 and fixed in 4% paraformalde-
yde in phosphate-buffered saline as previously
escribed (17,19). Briefly, the infrarenal aortic tract
hat was analyzed by CEU imaging was cut into
-mm thick cross sections and embedded in paraf-
n. Serial sections (5-m thick) were obtained and
tained with combined Masson elastin stain and
ematoxylin and eosin. Additional serial sections
ere assessed for macrophage and smooth muscle
ell density by using specific antibodies against
AM-11 (1:100 dilution, Dako, Carpenteria, Cal-
fornia) and -actin (1:100 dilution, Sigma-
ldrich, St. Louis, Missouri), respectively. Isolectin
4 (1:100 dilution, Vector Laboratories, Burlin-
ame, California), staining was performed for char-
cterization and quantification of neovessels. Neg-
tive controls were obtained omitting the primary
ntibodies.
Planimetric analysis of the cellular composition
f the lesions was performed using a computer-
ased quantitative color image analysis system
Image-Pro Plus, MediaCybernetics, Bethesda,
aryland) to assess the percentage of the RAM-11–
nd -actin–stained area for each section. The mac-
ophage and smooth muscle cell density of atheroscle-
otic plaques were quantified and expressed as the
ercentage of plaque area. The number of neovessels
as counted and related to the cross-sectional plaque
rea. Neovessel density (n/mm2) was used for corre-
ation with imaging data.
tatistical analyses. Data are presented as mean 
D or as median with minimum and maximum if
ot normally distributed. Test of normality was
erformed using Kolmogorov-Smirnov and
hapiro-Wilk tests. One-way analysis of variance
as used to compare differences between groups.
he Kruskal-Wallis test was used as appropriate
o compare differences between groups for not
ormally distributed variables (contrast enhance-
ent at computerized analysis, RAM-11). Pear-
on correlation was applied for linear association
etween contrast enhancement and intraplaque
eovascularization.
E S U L T S
EU imaging. Atherosclerotic lesions at the infrare-
al tract of aorta were detected in all the animals
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1259sing standard ultrasound examination. A total of
1 lesions were identified. Eight plaques (38%)
ere classified as class II (predominantly echolu-
ent), whereas the remaining 13 lesions (62%) were
ategorized as class III (predominantly echogenic)
15). No atherosclerotic plaques were detected in
he control unmanipulated animals.
After administration of the contrast agent, the
ortic lumen appeared opaque for approximately 1
in in both normal and atherosclerotic rabbits.
therosclerotic lesions, dark and hypoechoic before
ontrast agent injection, became bright and visible
0 to 60 s later due to the penetration of contrast
ithin the lesion and remained visible for up to 5
in. Observed contrast enhancement was repre-
ented by moving bright spots within the plaque
Online Video 1). In contrast, no signal enhance-
ent was evident in control (nonatherosclerotic)
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Figure 1. Contrast Enhancement at Computerized Analysis in A
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(A) Plaques classiﬁed as contrast-enhanced (CE) plaques at visual an
analysis compared with CE-negative lesions. (B) Class II predominan
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Figure 2. Histological Characterization of Atherosclerotic Lesion
(A) Plaque area was similar in both contrast-enhanced (CE) and non
(macrophages) were detected in CE than in non-CE lesions. (C) In c
was similar in both type of lesions.nimals. No lesions were apparent after saline
dministration in atherosclerotic animals. Images
btained with CEU were used to classify lesions
nto CE positive (53%) or CE negative (47%) by
isual examination. CE-positive lesions showed a
reater plaque enhancement when evaluated by the
emiautomated computerized analysis compared
ith CE-negative plaques (Fig. 1A). Lesions clas-
ified as class III (predominantly echogenic) dis-
layed a significantly higher contrast enhancement
ompared with class II or predominantly echolucent
esions (Fig. 1B). No contrast enhancement, by
ither visual or computerized analysis, was observed
n control animals.
orrelation between histology and CEU imaging. His-
ological analysis showed no significant differences in
laque size between the CE-positive and CE-negative
esions (Fig. 2A). However, CE-positive lesions were
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1260ssociated with a significantly higher density of mac-
ophages (RAM-11–positive staining) than the CE-
egative ones (Fig. 2B). On the other hand, no
ifference was observed in the density of smooth
uscle cells (-actin–positive staining) between the 2
roups of lesions (Fig. 2C). Similar results were found
hen the plaques were categorized according to their
chogenic class. No significant difference in plaque
Figure 3. Neovessel Density in Atherosclerotic Lesions Classiﬁed
(A) The total number of vessels was signiﬁcantly higher in contrast-
contrast enhancement was related to increased intraplaque neovas
adventitial (C), neovessel density in CE- versus non-CE plaques.
ive Images Showing CE-Positive Plaque Composition
)–positive lesions showed increased neovessel density (A) and
inﬁltration (B). In contrast, smooth muscle cell content (C) was
d in CE-negative lesions. Masson’s trichrome staining shows the
lastin (black) content of CE-positive lesions, which was lowero
aques.rea was detected between class II and class III lesions
5.8 1.4 mm2 vs. 6.6  1.0 mm2, respectively; p
.1). In contrast, class III lesions showed a signifi-
antly higher content of RAM-11–positive cells
1.6 0.8% vs. 3.2 0.6%, respectively; p 0.001);
-actin–positive cell (smooth muscle cells) density was
o different between class II and III plaques (1.9 0.4
s. 1.9  0.5, respectively; p  0.9). Class II lesions
howed a significantly higher collagen content than
lass III plaques (43.2  9.8% vs. 31.2  7.3%,
espectively; p  0.01); elastin content was similar in
oth groups (17.6 4.4% vs. 17.8 3.5%; p 0.9).
imilar findings were detected when lesions were
lassified according to their contrast enhancement.
E-negative plaques showed a significantly greater
ollagen content than CE-positive ones (41.8 8.5%
s. 30.1  7.0%, respectively; p  0.04), whereas the
lastin component was similar in both groups (18.2
.1% vs. 17.9  6.3%; p  0.8).
From the imaging view point, an interesting
bservation was the higher number of neovessels in
he arterial wall (adventitia and plaque) in CE-
ositive lesions compared with the CE-negative
esions (Fig. 3A). A more detailed analysis clearly
howed that the difference was mostly due to the
ncreased intraplaque angiogenesis (plaque vaso-
um) (Fig. 3B); the number of adventitial neovessels
as similar among the different lesions (Fig. 3C).
hese findings are in line with the selected CEU
maging criteria at visual examination defining as
E-positive those lesions with signal contrast agent
nhancement within the lesion, and as CE-negative
hose lesions with no signal within the plaque or
onfined to the plaque adventitial side.
It is important to note that similar findings were
btained when comparing the cellular composition
cording to Visual Contrast Enhancement
anced (CE) than in non-CE atherosclerotic lesions. The increased
rization as demonstrated by the higher intraplaque (B), but notAc
enh
culaFigure 4. Representat
Contrast-enhanced (CE
increased macrophage
similar to that observe
collagen (green) and ef the lesions classified according to their echogenic
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1261lass. Class III plaques showed a significantly
igher total neovessel density compared with class
I lesions (40.3  16.0 N/mm2 vs. 35.7  94.0
/mm2, respectively; p  0.4). These plaques were
lso associated with a significantly increased plaque-
asorum density than class II lesions (38.1  16.8
/mm2 vs. 23.7  7.6 N/mm2, respectively; p 
.05). In contrast, adventitial neovessels were sim-
lar between class II and III lesions (13.1  1.3
/mm2 vs. 11.7  4.0 N/mm2, respectively; p 
.3). Figure 4 shows representative images indicat-
ng the plaque composition of a CE-positive
laque, characterized by a greater content of mac-
ophages and neovessels. Figure 5 shows represen-
ative images of a CE-negative plaque, character-
zed by a lower neovessel and macrophage density
ut a greater fibrotic component.
A positive correlation between the number of
ntraplaque neovessels and contrast signal enhance-
ent of the lesions was noted (Fig. 6). Figures 6A
hrough 6C show the strong contrast enhancement
f a CE plaque and the corresponding pathological
pecimen showing high density of neovessels at
mmunohistochemistry (Figs. 6E and 6F).
I S C U S S I O N
e have described the feasibility of CEU imaging
or the noninvasive, in vivo visualization of neovas-
ularization in atherosclerotic lesions in a rabbit
odel of advanced atherosclerosis. The findings
ere corroborated by histological analyses of the
orresponding lesions. The increased plaque angio-
enesis associated with macrophage-rich lesions
as clearly identified by rapid contrast enhance-
ent of the lesions. On the other hand, more
brotic lesions with lower macrophage content did
ot show a similar enhancement. The specificity of
he contrast agent used in the study was demon-
trated by the lack of lesion enhancement after
aline administration in atherosclerotic animals.
imilarly, no contrast enhancement in nonath-
rosclerotic control rabbits after contrast injec-
ion was observed.
It is important to outline that the greater neoves-
el density at histology was observed in CE-positive
esions than in CE-negative lesions. These findings
re in agreement with previous data showing a good
orrelation between vasa vasorum and the degree of
ontrast agent enhancement in human atheroscle-
otic lesions (15). However, the atherosclerotic
esions used in that study were highly stenotic
ecause they had to meet the criteria for endarterec-omy and therefore did not include lesions with50%
tenosis (20,21). In fact, the high-risk lesions may not
lways be highly stenotic (22). The use of an animal
odel of atherosclerosis overrides this limitation, al-
owing the inclusion of lesions with a greater degree of
tenosis. The present study classified lesions not only
ccording to their contrast enhancement but also the
istological cellular composition and neovessel density
f the imaged lesions.
Interestingly, CEU imaging was able to differ-
ntiate plaques according to their vascularization
espite their similar sizes. Our results also show a
igher macrophage density in CE-positive than in
E-negative plaques, whereas vascular smooth
uscle cell density was similar in both groups.
oreover, CE-negative lesions were characterized
y a greater fibrotic component than CE-positive
laques. These observations are concordant with
hose of a previous report showing the relationship
etween neovascularization assessed by contrast
gent enhancement and plaque composition, irre-
pective of plaque size (15).
Similar results were found when categorizing the
therosclerotic lesions according to their echogenic-
ty. Class III lesions, which showed a significantly
Figure 5. Representative Images Showing CE-Negative Plaque C
Contrast-enhanced (CE)–negative lesions showed poor intraplaque
(A) and lower macrophage density (B) than CE-positive lesions. Smo
tent (C) was similar to CE-positive lesions. Increased ﬁbrotic compoomposition
neovascularization
oth muscle cell con-
nent detected byMasson’s trichrome staining (D) was signiﬁcantly greater than in CE-positive lesions.
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1262reater increase in contrast enhancement compared
ith class II plaques, demonstrated a similar plaque
rea but a greater content of macrophages compared
ith class II lesions. Class III lesions were also
haracterized by increased neovessel density than
lass II plaques. These results further confirm that
n predominantly echogenic lesions, the increased
acrophage density was associated with higher
eovessel content, a finding in line with previous
bservations showing that increased density of in-
raplaque neovessels is associated with plaque insta-
ility (23–25) as well as increased macrophage
nfiltration (7,15,26). The possibility of directly imag-
ng increased neovascularization may significantly im-
rove plaque characterization over traditional ultra-
ound. In fact, despite our findings showing that
redominantly echogenic lesions also show increased
eovascularization and macrophage density, CEU im-
ging may provide a unique opportunity to monitor
he serial progressive pathophysiological developments
f intraplaque neovessels (27). Moreover, future ap-
lication using targeted microbubbles targeting mark-
rs of endothelial activation/dysfunction or damage or
ngiogenesis receptors (28–31) might help to eluci-
ate the mechanism underlying neoangiogenesis in
therosclerosis.
Another novelty of this study concerns the signifi-
ant association seen between CE-positive lesions and
Figure 6. Representative Ultrasound Images of a CE-Positive At
Before (A) and after (B) contrast-administration. (C) Contrast enhanc
depicts contrast enhancement of the representative contrast-enhan
total number of neovessels and the signal enhancement in ﬁbrofatt
(F), a histological section of the imaged atherosclerotic plaque stain
ing area in the ultrasound images and in the histological section fro
corresponding luminal surface of the plaques in the ultrasound imalaque vasorum but not adventitial neovessels com- cared with CE-negative lesions. These findings sug-
est that contrast enhancement specifically reflects
ntraplaque rather than adventitial vascularization.
ifferent results have been reported by others (13,16)
escribing increased adventitial and intraplaque neo-
ascularization detected by CEU imaging in human
arotid atherosclerotic lesions. However, those obser-
ations were not corroborated by the systematic his-
ological evaluation of the imaged lesions.
A likely explanation for our findings showing no
orrelation between contrast enhancement and ad-
entitial neovessels could be related to the speed of
enetration of the contrast. Indeed, after contrast
njection, the lumen was opacified for about 1 min,
ot allowing any earlier evaluation of contrast en-
ancement. Therefore, it is possible that adventitial
eovessel enhancement, mostly occurring in this
arly phase, is actually either underestimated or
ndetectable. Moreover, a careful adjustment of
maging settings is required to detect contrast agent
icrobubbles penetrating plaque tissue. After tissue
ignal suppression, however, the plaque appears
ark, allowing easy detection of the microbubbles,
he adventitia remains bright, and this could actually
imit the detection ability of the technique. Finally,
lthough the experimental animal model used in the
resent study is characterized by advanced human-like
therosclerotic lesions, as measured by not only lipid
sclerotic Lesion
ent quantiﬁcation by digital subtraction imaging. Green area
(CE)–positive lesion. (D) Positive strong correlation between the
sions is shown. At 25 magniﬁcation (E) and 200 magniﬁcation
for lectin (neovessels) is shown. Asterisk indicates the correspond-
he same atherosclerotic lesion. Arrows in E and F indicate the
and in the histological section from the same animal.hero
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clerotic lesions.
O N C L U S I O N S
he results of the present study support CEU
maging as a feasible technique for the noninvasive
ssessment of intraplaque neovascularization. Sev-
ral findings suggest that intraplaque neovascular-
zation is associated with plaque progression and
ulnerability (9). Therefore, the availability of a
oninvasive technique to assess lesion neovascular-
zation could be of great importance to identify
ighly vascularized lesions. It has been suggested
hat inhibition of plaque neovessels could be agiogenesis as a source of intraplaque 2009;10:260–4.rosclerotic lesion stabilization. Therefore, the non-
nvasive assessment of plaque neovascularization
ould be of great importance in detecting the
resence of highly vascularized lesions and possibly
o establish the intensity of antiatherosclerotic
reatments (i.e., lipid-lowering approaches).
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